NDT Pharmaceuticals (NDTP, $0.07) was a top loser over the last three months, falling to $0.07 per share. A.I.dvisor analyzed 860 stocks in the Biotechnology Industry for the 3-month period ending September 9, 2024, and found that of them (4) exhibited an Uptrend while of them (5) demonstrated a Downtrend.